SCA
USNA icon

SAC Capital Advisors’s Usana Health Sciences USNA Stock Holding History

SAC Capital Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,058
Closed -$454K – 979
2014
Q1 		$454K Sell
12,058
-3,900
-24% -$136K ﹤0.01% 1231
2013
Q4 		$603K Buy
15,958
+7,408
+87% +$283K ﹤0.01% 1091
2013
Q3 		$371K Buy
8,550
+2,144
+33% +$86K ﹤0.01% 1282
2013
Q2 		$232K Buy
+6,406
New +$195K ﹤0.01% 1407

Other funds holding USNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SAC Capital Advisors's USNA Position: Q2 2014 in Review

SAC Capital Advisors sold out of Usana Health Sciences (USNA) in Q2 2014, closing a stake of 12,058 shares — an estimated $454K sold.

SAC Capital Advisors first reported a position in USNA in Q2 2013 and held it in 4 quarters. The position peaked at $603K in Q4 2013. 123 funds tracked by Wall St. Rank hold USNA as of Q2 2014.

  • SAC Capital Advisors reported no remaining Usana Health Sciences position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 12,058 Usana Health Sciences shares in Q2 2014, an estimated $454K.
  • SAC Capital Advisors first reported a position in Usana Health Sciences in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Usana Health Sciences position peaked at $603K in Q4 2013.
  • 123 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.